Budget
€10 — €0
EP Access
0
accredited persons
Staff
1
0.25 FTE
EU Grants
None
Mission & Goals
Corlife entwickelt und produziert am Firmensitz in Hannover innovative Produkte für die Herzchirurgie. Das Hauptaugenmerk liegt dabei auf zellfreien, regenerativen Gewebeimplantaten, die vor allem bei der Korrektur angeborener Herzfehler angewendet werden.
EU Legislative Interests
Stakeholder consultation for the evaluation of EU legislation on substances of human origin (SoHo). Participation in the Commissions public consultation on a new regulation on standards of quality and safety for substances of human origin intended for human application (Soho). corlife gave feedback to the commissions adoption under the umbrella of the organisation BPI on 31.08.2022.
Communication Activities
On 10.10.2023 the BPI had a meeting with EU parlamentarians ( Lena Düpont / EVP, CDU and Rasmus Andresen / Freie Europäische Allianz, Grüne) in Brussels concerning the SoHo regulation. For this meeting also corlife was invited and had been able to discuss about this topic with the parlamentarians.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
The German Pharmaceutical Industry Association (BPI) represents the interests of around 260 pharmaceutical and biotech companies in Germany with approximately 70,000 employees: start-ups, SMEs and multinational companies. www.bpi.de The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent. BPI is member of the EUCOPE (www.eucope.org)
Organisation Members
n.a.
Commissioner Meetings
No recorded meetings with EU commissioners.